Titomic Raises A$16.5 Million to Accelerate US Facility Expansion and Board Growth
Titomic has raised A$16.5 million through an institutional placement priced at a 23.5% discount, aiming to scale its Huntsville facility and accelerate US growth. The company also advanced a US$10 million loan application with the Export-Import Bank and appointed aerospace veteran Jim Chilton to its board.
- A$16.5 million placement at A$0.13 per share
- Funds targeted at Huntsville facility expansion and technical hires
- US$10 million Export-Import Bank loan application progressing
- Appointment of aerospace and defense veteran Jim Chilton to board
- Operational runway extended to projected 2027 cashflow breakeven
Capital Raise Fuels US Growth Ambitions
Titomic Limited (ASX:TTT) has secured a A$16.5 million institutional placement, issuing approximately 126.9 million new shares at A$0.13 each; representing a 23.5% discount to its last closing price. This capital injection aims to underpin the company’s push to scale its Huntsville, Alabama facility and accelerate expansion within the US industrial base.
The funds will be deployed across several fronts: adding equipment to boost manufacturing capacity, recruiting technical and production staff, enhancing technology and automation, and shoring up working capital. Crucially, this placement extends Titomic’s operational runway to projected cashflow breakeven during 2027, providing breathing room to pursue growth initiatives without immediate funding pressure.
US Government Financing and Board Reinforcement
In a strategic governance move, Titomic announced the appointment of Jim Chilton, a seasoned US aerospace and defense executive, to its board. This addition aligns with the company’s redomicile plans to the US, expected in the fourth quarter of 2026, and signals a deepening focus on the aerospace and defense sectors.
Momentum in Orders and Market Positioning
Executive Chairman Dag W.R. Stromme highlighted recent traction, noting four new orders received in the past two weeks and forecasting a strong uptick in global orders for the remainder of 2026. This momentum comes as Titomic leverages its proprietary Titomic Kinetic Fusion™ cold spray technology across aerospace, defense, mining, and automotive sectors.
The company’s Huntsville facility serves as a global headquarters and a key node in its industrial-scale metal additive manufacturing network. The placement proceeds will help scale production capacity and enhance digital and automation capabilities, critical for meeting anticipated demand growth.
Placement Pricing and Shareholder Impact
The placement represents about 7.9% of Titomic’s existing shares, issued within the company’s placement capacity under ASX Listing Rule 7.1. Shares are expected to settle on 7 September 2026 and commence trading on 8 September. The discounted pricing reflects a common approach to incentivise institutional participation but dilutes existing shareholders to some extent.
Investors should weigh the near-term dilution against the longer-term potential of an expanded US footprint and strengthened balance sheet. The company’s ongoing redomicile process and US market focus have been closely watched by shareholders, with the latest capital raise reinforcing commitment to these strategic priorities.
Bottom Line?
Titomic’s capital raise and potential US government loan bolster its US expansion and production scale-up, but the final impact hinges on execution and loan approval.
Questions in the middle?
- Will the US$10 million EXIM loan secure final approval and on what terms?
- How quickly can Titomic ramp production capacity at Huntsville to meet rising orders?
- What strategic influence will new board member Jim Chilton have on US market penetration?